The row over vaccines between
AstraZeneca and the EU intensified on Wednesday, with the company suggesting EU governments are getting âemotionalâ and the EU saying factories in Britain should make vaccines for the bloc. Naomi OâLeary has the latest.
Karlin Lillington also considers AstraZeneca vaccines in her column, specifically the erroneous claims made about them in the German media this week. She argues the episode provides useful insights into how easily misinformation and disinformation can spread online.
Yew Grove Reit, the Dublin-listed owner of office and industrial assets, is eyeing a â¬50 million share sale as soon as late March to reboot its growth strategy, writes Joe Brennan. The groupâs chief executive notes that its plans to fundraise last year were put back by 12 months at least.